We have applied some changes to ARIA and are monitoring stability, but you can continue to work as normal. We appreciate your understanding.
05-Mar-2026
The Fragment-Screen project is developing new technologies, services, and experimental workflows to advance fragment-based screening and accelerate its adoption across Research Infrastructures. This pilot call provides funded access for external research teams to test access and evaluate some of these technologies through real fragment-screening research questions.
Results and feedback from selected projects will contribute to improving and optimising the developed workflows prior to broader deployment. The Fragment-Screen project will support a minimum of two funded pilot access projects through this call. Successful applicants will be able to use their requested Fragment-Screen service free of charge, and a contribution of €500 is available to support travel and shipping expenses.
Applications close 14 April 2026, and successful applicants will be selected by 14 May 2026.
For more information on participating facilities, services available and guidance on applying for access, please see the application page.
The Fragment-Screen project is developing innovative instrumentation, workflows and experimental and computational methodologies for fragment-based drug discovery to enable access to early phase structure-based drug discovery for all biological targets and for scientists both in industry and academia. Fragment-Screen brings together scientists from ESRF (the European synchrotron), EU-OPENSCREEN ERIC (medicinal chemistry), and ELIXIR (data resources for life science) under the coordination of Instruct-ERIC (integrated structural biology) and seven industry partners to remove crucial bottlenecks in early phase drug discovery.
You can visit the Fragment Screen website here.
